Illumina Q2 2025 Earnings Call Transcript Highlights

domingo, 3 de agosto de 2025, 5:25 pm ET1 min de lectura
ILMN--

Illumina reported Q2 2025 earnings with total revenue of $1.06 billion, down 3% YoY. Non-GAAP EPS was $1.19, up 9% YoY. Sequencing consumables revenue was $740 million, approximately flat YoY. The company raised full-year revenue guidance for Greater China by $25 million to $200 million. Over 80% of research sequencing volume and 55% of clinical sequencing volume have transitioned to NovaSeq X.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios